| 货号 | 14066 |
| 描述 | Pharmacology: JQ1 is a potent BET bromodomain inhibitor. (IC50 = 17.7, 32.6, 76.9 and 12942 nM respectively for BRD2 (N-terminal), BRD4 (C-terminal) and CREBBP (data for + isomer))(ref 1). Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models (ref 1). Induces squamous differentiation in NMC cell lines and inhibits tumor growth in NMC xenografts (ref 2). Blocks inflammation and bone loss in periodontitis (ref 3). Displays reversible contraceptive effects in male mice (ref 4). Note: This product is racemic (+/-) making the IC50 nominally 2-fold greater than literature values for the (+) isomer. |
| 别名 | JQ1 (+/-), JQ1 racemic, (6R,S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid 1,1-dimethylethyl ester |
| 供应商 | Active Motif |
| 运输条件 | Blue Ice |
| 存放说明 | Store desiccated as supplied at room temperature for up to 1 year. Store solutions at -20°C for up to 2 months. |
| 纯度 | >98% (TLC); NMR (Conforms) |
| 计算分子量 | 457.0 |
| 分子式 | C23H25ClN4O2 |
| CAS号 | 1268524-70-4 |
| 外观 | White powder. May be dissolved in DMSO (40 mg/ml); Ethanol (40 mg/ml). |
| 参考文献 | 1. P Filippakopoulos et al. Nature 2010, 468:1067 2. H Hermann et al. Oncotarget 2012, 3:1588 3. S Meng et al. Dent. Res. 2014, 93:657 4. MM Matzuk et al. Cell 2012, 150:673 |
| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |
Chemical Structure of JQ1 racemic. |
